Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients - ScienceDirect
A case report of late‐onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review - Parisi - 2021 - Brain and Behavior - Wiley Online Library
Frontiers Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
atypical hemolytic uremic syndrome - List of Frontiers' open access articles
Eculizumab for Atypical Hemolytic–Uremic Syndrome
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome - ScienceDirect
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
PDF] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Frontiers Case report: Short-term eculizumab use in atypical HUS associated with Lemierre's syndrome and post-infectious glomerulonephritis
PDF) Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
de
por adulto (o preço varia de acordo com o tamanho do grupo)
